Biggest News Aggregation in the World
📰 Practice Guidelines News

Page 45 - Practice Guidelines News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.

BeiGene Announces European Medicines Agency Acceptance of Applications for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia and Marginal Zone Lymphoma

BeiGene Announces European Medicines Agency Acceptance of Applications for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia and Marginal Zone Lymphoma - read this article along with other careers information, tips and advice on BioSpace
United States New Zealand United Kingdom Great Britain Jane Huang National Cancer Institute

New ERLEADA® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA®...
United States San Francisco Benjamin Lowentritt Tracy Mcgowan Paloma Feliciano Janssen Biotech Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New ERLEADA® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA®...
United States San Francisco Benjamin Lowentritt Tracy Mcgowan Paloma Feliciano Janssen Biotech Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science